It was reported that transient disruption of the SDF‐1/CXCR4 axis using CXCR4 blocking antibody blocked the recruitment of bone marrow‐derived cells into the angiogenic sites of tumour tissue, and resulted in an inhibition of accelerated tumour growth.15 Here, CXCL12 is linked to neoplasm.